...
首页> 外文期刊>Journal of Contemporary Brachytherapy >Dosimetric comparison of two different applicators and rectal retraction methods used in inverse optimization-based intracavitary brachytherapy for cervical cancer
【24h】

Dosimetric comparison of two different applicators and rectal retraction methods used in inverse optimization-based intracavitary brachytherapy for cervical cancer

机译:两种不同涂布器与直肠收缩方法的编号比较,用于颈癌颈内近距离放射治疗

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose The purpose of this study was to evaluate the dosimetric differences between two different applicators and rectal-retraction methods used in image-guided brachytherapy (IGBT) for locally advanced cervical cancer (LACC). Material and methods Ten patients with LACC treated with definitive chemoradiotherapy and inverse optimization-based IGBT were included in this study. In each patient, at least one fraction of IGBT was performed using tandem-ovoids (TO) with vaginal gauze packing (VGP) or tandem-ring (TR) with rectal-retractor (RR). High-risk clinical target volume (CTVSUBHR/SUB) and intermediate-risk CTV (CTVSUBIR/SUB) were defined as CTVs, and bladder, rectum, sigmoid, small bowel, urethra, and vaginal mucosa were defined as organs at risk (OARs). All patients received 50.4 Gy external beam radiotherapy (EBRT) in 28 fractions. After EBRT, 28 Gy high-dose-rate (HDR) IGBT in 4 fractions was delivered to central disease. A plan comparison was performed using dose-volume histogram (DVH) and treatment planning parameters for CTVs and OARs. Results There were no significant differences in DSUB90/SUB values of CTVSUBHR/SUB. In terms of rectum dose, TR with RR was found to be significantly better than TO with VGP (p 0.0001 for Dsub2cmsup3/sup/sub and p 0.013 for Vsub5Gy/sub). Although, there were no statistically significant differences in Dsub2cmsup3/sup/sub value of bladder, sigmoid, small bowel, upper vaginal mucosa, and urethra, mean value of Dsub2cmsup3/sup/sub for all defined OARs were found lower in TR than in TO. Bladder Vsub7Gy/sub, upper vaginal mucosa Vsub7Gy/sub, middle and lower vaginal mucosa Dsub2cmsup3/sup/sub values were all found to be significantly lower for TR than for TO (p 0.035). CTVSUBHR/SUB and CTVSUBIR/SUB volumes contoured in TR were approximately 11% and 9% smaller than TO, respectively. Conclusions The results showed that there were no statistically differences in DSUB90/SUB value of CTVSUBHR/SUB and CTVSUBIR/SUB. However, all DVH parameters for OARs in TR with RR were found to be better than in TO with VGP.
机译:目的本研究的目的是评估两种不同涂抹器与局部晚期宫颈癌(LACC)中使用的两种不同涂抹器和直肠缩回方法之间的剂量差异。本研究纳入了用明确的化学疗法和逆优化的IGBT治疗的LACC患者的材料和方法。在每只患者中,使用具有阴道纱布包装(VGP)或串联环(TR)的串联卵体(至)使用串联卵络(至)或具有直肠牵引器(RR)的串联环(TR)进行至少一种IGBT。高风险的临床靶体积(CTV Hr )和中性风险CTV(CTV IR )被定义为CTV和膀胱,直肠,乙状胺,小肠,尿道,尿道,阴道粘膜被定义为风险(OAR)的器官。所有患者均在28分级分中接受50.4 Gy外梁放射疗法(EBRT)。在EBRT中,将28种高剂量率(HDR)IGBT递送至中央疾病。使用剂量直方图(DVH)和CTV和OAR的治疗计划参数进行计划比较。结果CTV Hr 的D 90 值没有显着差异。就直肠剂量而言,发现具有RR的TR显着优于VGP(对于D 2cm> 3 3 和p <0.013的p <0.0001) 5Gy )。虽然,D 2cm 3 值没有统计学上显着的差异,膀胱,sigmoid,小肠,上部阴道粘膜和尿道,平均值D 2cm对于所有定义的桨的 3 在tr中较低而不是。膀胱V 7ggy ,上部阴道粘膜v 7ggers ,中间和下部阴道粘膜d 2cm 3 值都已找到对于TR的明显低于(P <0.035)。 CTV Hr 和CTV Ir 在Tr中的Ir 体积分别比分别为小于11%和9%。结论结果表明,CTV hr 和ctv Ir 的D 90 值没有统计学差异。然而,发现具有RR的TR中的OAR的所有DVH参数比VGP更好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号